Rifamycin C-11 oxime derivatives effective against...

Details Rifamycin C-11 oxime derivatives effective against... Rifamycin C-11 oxime derivatives effective against...

2007-08-14

2007-08-14

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253010, C514S253050, C514S253080, C514S254020, C514S254110, C514S300000, C514S321000, C514S339000, C540S456000

Reexamination Certificate

active

11076172

ABSTRACT:
The invention relates to rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms, specifically, the rifamycin derivatives having an oxime group at the C-11 position.

REFERENCES:
patent: 4002754 (1977-01-01), Cricchio et al.
patent: 4164499 (1979-08-01), Rossetti et al.
patent: 4341785 (1982-07-01), Marchi et al.
patent: 0190709 (1989-12-01), None
patent: 0228606 (1991-02-01), None
patent: WO94/28002 (1994-12-01), None
patent: WO93/051299 (2003-06-01), None
Bartolucci, C., et al.,Synthesis, Reactivity Studies, and X-Ray Crystal Structure of (11R)-25-O-Deacetyl-11-deoxo-11-hydroxy-21 ,23-O-isopropylidenerifamycin S; Helvetica Chimica Acta, 1990, vol. 73, pp. 185-190.
Brufani, M., et al., Rifamycins: an Insight into Biological Activity Based on Structural Investigations, 1974, vol. 87, pp. 409-435.
Bundgaard, H., et al., (c) Means to Enhance Penetration (1) Prodrugs as a Means to improve the delivery of peptide drugs, Advanced Drug Delivery Reviews, 8 (1992) pp. 1-38.
Farr, B. M., Rifamycins, in Principles and Practices of Infectious Diseases; Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases, Churchill Livingstone, Philadelphia, pp. 348-361, (2000).
Kakeya, N., et al., Studies on Prodrugs of Cephalosporins. I. Synthesis and Biological Properties of Glycyloxybenzoyloxymethyl and Glycylaminobenzoyloxymethyl Esters of 7b-[2-(2-Aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-methyl-3-cephem-4-carboxylic Acid, Chem Phar Bull, 1984, vol. 32, pp. 692-698.
Neilsen, N.M, et al.; Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physiochemcial Properties; Journal of Pharmaceutical Sciences; Apr. 1988; vol. 77, pp. 285-298.
Bundgaard, H.; Design and Application of Prodrugs; A Textbook of Drug Design and Development; Krosgaard-Larsen and Bundgaard, H., eds.; 1991, Chapter 5, pp. 113-191.

Affiliated with

Also associated with

Rating

Rifamycin C-11 oxime derivatives effective against... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rifamycin C-11 oxime derivatives effective against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rifamycin C-11 oxime derivatives effective against... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3866214